These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M, Yamaji T. J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [Abstract] [Full Text] [Related]
3. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. Ishibashi M, Yamaji T. J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494 [Abstract] [Full Text] [Related]
5. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. Renner U, Brockmeier S, Strasburger CJ, Lange M, Schopohl J, Müller OA, von Werder K, Stalla GK. J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966 [Abstract] [Full Text] [Related]
6. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly. Ishibashi M, Yamaji T. J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426 [Abstract] [Full Text] [Related]
7. Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues. Chihara K, Iwasaki J, Minamitani N, Kaji H, Matsukura S, Tamaki N, Matsumoto S, Fujita T. J Clin Endocrinol Metab; 1982 Apr; 54(4):773-9. PubMed ID: 6120948 [Abstract] [Full Text] [Related]
11. [In vitro secretion of somatostatin (SRIH) by human adenomatous somatotropic cells. Relation with somatotropic hormone (GH) release and modulation by thyroliberin (TRH)]. Peillon F, Liappi G, Garnier P, Brandi AM, Evain-Brion D, Dodeur M, Gautron JP, Donnadieu M, Michard M, Racadot J. C R Acad Sci III; 1988 Apr; 306(4):161-6. PubMed ID: 2896067 [Abstract] [Full Text] [Related]
15. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells. Kuzuya N, Inoue K, Ishibashi M, Murayama Y, Koide Y, Ito K, Yamaji T, Yamashita K. J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960 [Abstract] [Full Text] [Related]
16. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly. Lamberts SW, Verleun T, Oosterom R. J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175 [Abstract] [Full Text] [Related]
17. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas. Chang CC, Chen FW, Hsieh HC. Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734 [Abstract] [Full Text] [Related]
18. Growth hormone secretion from chicken adenohypophyseal cells in primary culture: effects of human pancreatic growth hormone-releasing factor, thyrotropin-releasing hormone, and somatostatin on growth hormone release. Perez FM, Malamed S, Scanes CG. Gen Comp Endocrinol; 1987 Mar; 65(3):408-14. PubMed ID: 2881841 [Abstract] [Full Text] [Related]
19. Effect of pancreatic growth hormone releasing factors on GH secretion by human somatotrophic pituitary tumours in cell culture. Adams EF, Bhuttacharji SC, Halliwell CL, Loizou M, Birch G, Mashiter K. Clin Endocrinol (Oxf); 1984 Dec; 21(6):709-18. PubMed ID: 6150773 [Abstract] [Full Text] [Related]